CVE:THCX Hydropothecary (THCX) Stock Price, News & Analysis C$5.30 +0.33 (+6.64%) As of 06/21/2018 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Hydropothecary Stock (CVE:THCX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Hydropothecary alerts:Sign Up Key Stats Today's RangeC$5.00▼C$5.3750-Day RangeC$5.30▼C$5.3052-Week RangeC$1.10▼C$5.42Volume5.38 million shsAverage Volume2.35 million shsMarket CapitalizationC$949.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewThe Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.Read More… Receive THCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hydropothecary and its competitors with MarketBeat's FREE daily newsletter. Email Address THCX Stock News HeadlinesAXS CANNABIS ETF ESTIMATED CASH (^THCX-EU)April 16, 2023 | finance.yahoo.comThe Hydropothecary Corporation (HEXO.TO)February 25, 2023 | uk.finance.yahoo.comThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?May 4, 2025 | Timothy Sykes (Ad)AXS Cannabis ETF (THCX)February 17, 2023 | finance.yahoo.comOutlook on the Medical Cannabis Global Market to 2027 - Emergence of Cannabis Legalization Presents Opportunities USA - English - USA - English - PR NewswireAugust 16, 2022 | prnewswire.comThe Worldwide Medical Cannabis Industry is Expected to Reach $24.8 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 15, 2022 | businesswire.comBedel Financial Consulting, Inc. Buys Innovator S&P 500 Power Buffer ETF - GuruFocus.comAugust 3, 2021 | gurufocus.comOptimum Investment Advisors Bu - GuruFocus.comAugust 2, 2021 | gurufocus.comSee More Headlines THCX Stock Analysis - Frequently Asked Questions How have THCX shares performed this year? Hydropothecary's stock was trading at C$5.30 at the beginning of the year. Since then, THCX shares have increased by 0.0% and is now trading at C$5.30. View the best growth stocks for 2025 here. How do I buy shares of Hydropothecary? Shares of THCX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Hydropothecary own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hydropothecary investors own include Canopy Growth (WEED), Aurora Cannabis (ACB), Aphria (APHA), Canopy Growth (CGC), Cronos Group (CRON), CannTrust (CTST) and Riot Platforms (RIOT). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:THCX CIKN/A Webwww.thehydropothecary.com Phone+1-416-7504949FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares179,077,000Free FloatN/AMarket CapC$949.11 million OptionableNot Optionable BetaN/A Free Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (CVE:THCX) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Hydropothecary Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Hydropothecary With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.